Mathilde Jalving

4.5k citations
125 papers · 3.4k · h-index 29

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Cancer survivorship and care
    • PARP inhibition in cancer therapy

Papers in

    • Cancer Immunotherapy and Biomarkers 24
    • Cutaneous Melanoma Detection and Management 9
    • PARP inhibition in cancer therapy 6
    • Ovarian cancer diagnosis and treatment 12

Mathilde Jalving

122 papers receiving 3.3k citations

Peers

Mathilde Jalving
Comparison fields: 5 of 117
  • Oncology 1.1k
  • Cancer Research 343
  • Gastroenterology 164
  • Radiology, Nuclear Medicine and Imaging 443
  • Molecular Biology 673
Replace Nobuhiko Oridate with:
Nobuhiko Oridate Japan
Suguru Hasegawa Japan
Desmond Yip Australia
Eliana Rulli Italy
James J. Farrell United States
Satoru Motoyama Japan
Björn L.D.M. Brücher Germany
Kazuo Hase Japan
Alexander A. Parikh United States
Mathilde Jalving relative to Nobuhiko Oridate Japan Nobuhiko Oridate's profile →
Citations per field
00.5×2×3×4.0×
Nobuhiko Oridate · 1×
Citations per year

Countries citing papers authored by Mathilde Jalving

Since Specialization
Citations

This map shows the geographic impact of Mathilde Jalving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Jalving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Jalving more than expected).

Fields of papers citing papers by Mathilde Jalving

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Jalving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Jalving. The network helps show where Mathilde Jalving may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathilde Jalving, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathilde Jalving Line = papers co-authored together Mathilde Jalving links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010333
2 2020282
3 2020245
4 2006207
5 2017183
6 2021126
7 202293
8 201789
9 202182
10 200366
11 201862
12 202062
13 202157
14 202050
15 202150
16 201545
17 201745
18 201945
19 200542
20 201742

About Mathilde Jalving

Mathilde Jalving is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 125 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Ovarian cancer diagnosis and treatment (12 papers), Cancer, Hypoxia, and Metabolism (9 papers), Metabolism, Diabetes, and Cancer (9 papers), Cutaneous Melanoma Detection and Management (9 papers), Medical Imaging Techniques and Applications (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and PARP inhibition in cancer therapy (6 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (343 citations), Gastroenterology (164 citations), Radiology, Nuclear Medicine and Imaging (443 citations) and Molecular Biology (673 citations). Mathilde Jalving has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Steven de Jong, Elisabeth de Vries, Ellen C. de Heer, Jourik A. Gietema, Adrian L. Harris, Anna K.L. Reyners, Jan J. Koornstra, Joop D. Lefrandt, Reinold O. B. Gans and Jelle Wesseling. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, ESMO Open, Cancers and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact